ALDER BIOPHARMACEUTICALS INC Insider Trading for October 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALDER BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALDER BIOPHARMACEUTICALS INC for October 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19 2016 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 27.50 | 2,000 | 55,000 | 26,000 | 28 K to 26 K (-7.14 %) |
| Oct 19 2016 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 27.50 | 2,000 | 55,005 | 26,000 | 28 K to 26 K (-7.14 %) |
| Oct 19 2016 | ALDR | ALDER BIOPHARMACEU ... | Litton Mark James | Chief Business Offi ... | Sell | S | 27.50 | 2,000 | 54,993 | 26,000 | 28 K to 26 K (-7.14 %) |
| Oct 11 2016 | ALDR | ALDER BIOPHARMACEU ... | Benedict Larry | EVP and PAO | Option Exercise | A | 30.20 | 30,000 | 906,000 | 30,000 | |
| Oct 11 2016 | ALDR | ALDER BIOPHARMACEU ... | Benedict Larry | EVP and PAO | Grant | A | 8.50 | 2,000 | 17,000 | 30,247 | 28.2 K to 30.2 K (+7.08 %) |
| Oct 07 2016 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | A | 31.47 | 225,000 | 7,080,750 | 225,000 | |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Sr. VP Translationa ... | Option Exercise | M | 1.65 | 3,000 | 4,950 | 27,363 | |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Sr. VP Translationa ... | Sell | S | 31.62 | 702 | 22,199 | 0 | 702 to 0 (-100.00 %) |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Sr. VP Translationa ... | Sell | S | 30.99 | 2,298 | 71,216 | 702 | 3 K to 702 (-76.60 %) |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Sr. VP Translationa ... | Buy | M | 1.65 | 3,000 | 4,950 | 3,000 | 0 to 3 K |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Option Exercise | M | 1.27 | 8,181 | 10,349 | 0 | |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 31.55 | 2,700 | 85,189 | 114,768 | 117.5 K to 114.8 K (-2.30 %) |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Sell | S | 30.95 | 5,481 | 169,622 | 117,468 | 122.9 K to 117.5 K (-4.46 %) |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Schatzman Randall C | President and CEO | Buy | M | 1.27 | 8,181 | 10,349 | 122,949 | 114.8 K to 122.9 K (+7.13 %) |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 1.65 | 10,000 | 16,500 | 13,636 | |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 31.51 | 6,249 | 196,888 | 242,200 | 248.4 K to 242.2 K (-2.52 %) |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Sell | S | 31.00 | 3,751 | 116,263 | 248,449 | 252.2 K to 248.4 K (-1.49 %) |
| Oct 05 2016 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Buy | M | 1.65 | 10,000 | 16,500 | 252,200 | 242.2 K to 252.2 K (+4.13 %) |